Literature DB >> 22727493

The use of transthoracic echocardiography and adherence to appropriate use criteria at a regional hospital.

Simone A Bailey1, Ionut Mosteanu, Patricia A Tietjen, Joann R Petrini, Jonathan Alexander, Andrew M Keller.   

Abstract

BACKGROUND: The sharp increase in health care costs over the past decade has prompted health care providers to reevaluate how diagnostic imaging is utilized. In response to the need for more rational use of imaging services, the American College of Cardiology Foundation and the American Society of Echocardiography have developed appropriate use criteria (AUC) for transthoracic echocardiography to guide its utilization. Although community and regional hospitals, such as Danbury Hospital, account for 85% of registered hospitals in the United States, very little is known about adherence to the AUC at these institutions.
METHODS: The electronic medical records of 1,205 patients who underwent inpatient transthoracic echocardiography from January 1 to June 30, 2008, were retrospectively examined to determine the reasons for ordering the studies. The 2007 and 2011 AUC were used to classify indications as appropriate, inappropriate, or uncertain.
RESULTS: Using the 2007 AUC, 86% of echocardiographic examinations were classified as appropriate. One percent had indications that were inappropriate, and there were no uncertain indications. Thirteen percent of studies were ordered for reasons not defined by the 2007 AUC. The most common appropriate indications were symptoms due to suspected cardiac etiology, initial evaluation after acute myocardial infarction, and acute chest pain with suspected myocardial ischemia. When evaluated using the 2011 AUC, appropriate and inappropriate indications increased to 97% and 2%, respectively. Ninety-three percent of undefined studies, using the 2007 AUC, could be classified using the 2011 guidelines.
CONCLUSIONS: Consistent with studies conducted at university hospitals, Danbury Hospital, a regional hospital, showed good adherence to the AUC. This suggests that the AUC are valuable across a large continuum of inpatient settings and can serve as an excellent guide for utilization and appropriateness.
Copyright © 2012 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727493     DOI: 10.1016/j.echo.2012.05.014

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  A systematic review of Appropriate Use Criteria for transthoracic echocardiography: are they relevant outside the United States?

Authors:  Robert N Kerley; Siun O'Flynn
Journal:  Ir J Med Sci       Date:  2018-06-18       Impact factor: 1.568

2.  Appropriateness vs value: Echocardiography in primary care.

Authors:  Amy Bethge; Oana Penciu; Salma Baksh; Swapnil Parve; Jessika Lobraico; Andrew M Keller
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

3.  Appropriate Use Criteria in Echocardiography: An Observational Institutional Study with the Perspective of a Quality Improvement Project.

Authors:  Vanessa Rameh; Antoine Kossaify
Journal:  Clin Med Insights Cardiol       Date:  2016-02-16

4.  Assessment of inpatient multimodal cardiac imaging appropriateness at large academic medical centers.

Authors:  Andrew Remfry; Howard Abrams; David M Dudzinski; Rory B Weiner; R Sacha Bhatia
Journal:  Cardiovasc Ultrasound       Date:  2015-11-14       Impact factor: 2.062

5.  How I do it: judging appropriateness for TTE and TEE.

Authors:  Ricardo Fonseca; Thomas H Marwick
Journal:  Cardiovasc Ultrasound       Date:  2014-06-24       Impact factor: 2.062

6.  Impact of a structured referral algorithm on the ability to monitor adherence to appropriate use criteria for transthoracic echocardiography.

Authors:  Steven Promislow; Joseph G Abunassar; Behnam Banihashemi; Benjamin J Chow; Girish Dwivedi; Kasra Maftoon; Ian G Burwash
Journal:  Cardiovasc Ultrasound       Date:  2016-08-15       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.